dc.contributor.author | Roche, James J. | |
dc.date.accessioned | 2019-10-24T08:02:40Z | |
dc.date.available | 2019-10-24T08:02:40Z | |
dc.date.copyright | 2008 | |
dc.date.issued | 2008-04 | |
dc.identifier.citation | Roche, J.J. (2008). Advanced therapies and the outer limits of DNA regulation: new horizons for patents or a scaffold too far? Journal of Intellectual Property Law & Practice. 3 (4), 210-212 | en_US |
dc.identifier.issn | 1747-1532 | |
dc.identifier.other | Articles - Life and Physical Sciences AIT | en_US |
dc.identifier.uri | http://research.thea.ie/handle/20.500.12065/2838 | |
dc.description.abstract | This Regulation seeks to regulate existing and future advanced therapy medicinal products intended for the market in Member States, being either prepared industrially or manufactured by a method involving an industrial process, and introduces additional provisions to those laid down in the pharmaceutical legislation Directive 2001/83. | en_US |
dc.format | PDF | en_US |
dc.language.iso | en | en_US |
dc.publisher | Oxford Academic | en_US |
dc.relation.ispartof | Journal of Intellectual Property Law & Practice | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Ireland | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ie/ | * |
dc.subject | Drugs - Law and Legislation | en_US |
dc.title | Advanced therapies and the outer limits of DNA regulation: new horizons for patents or a scaffold too far? | en_US |
dc.type | Article | en_US |
dc.description.peerreview | yes | en_US |
dc.identifier.doi | https://doi.org/10.1093/jiplp/jpn019 | |
dc.identifier.orcid | https://orcid.org/0000-0003-2995-3000 | |
dc.rights.access | Open Access | en_US |
dc.subject.department | Faculty of Science and Health | en_US |